Witnessing the stock’s movement on the chart, on Wednesday, Roivant Sciences Ltd (NASDAQ: ROIV) had a quiet start as it plunged -0.88% to $20.34, before settling in for the price of $20.52 at the close. Taking a more long-term approach, ROIV posted a 52-week range of $8.73-$21.35.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -99.51%. Meanwhile, its Annual Earning per share during the time was -99.51%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -376.28%. This publicly-traded company’s shares outstanding now amounts to $689.70 million, simultaneously with a float of $410.80 million. The organization now has a market capitalization sitting at $14.15 billion. At the time of writing, stock’s 50-day Moving Average stood at $17.42, while the 200-day Moving Average is $12.66.
Roivant Sciences Ltd (ROIV) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Roivant Sciences Ltd’s current insider ownership accounts for 40.93%, in contrast to 63.94% institutional ownership. According to the most recent insider trade that took place on Nov 14 ’25, this organization’s 10% Owner sold 1,027,670 shares at the rate of 20.33, making the entire transaction reach 20,892,531 in total value, affecting insider ownership by 34,193,406. Preceding that transaction, on Nov 17 ’25, Company’s 10% Owner sold 539,650 for 20.51, making the whole transaction’s value amount to 11,068,222. This particular insider is now the holder of 33,653,756 in total.
Roivant Sciences Ltd (ROIV) Earnings and Revenue Records
Roivant Sciences Ltd’s EPS decrease for this current 12-month fiscal period is -376.28% and is forecasted to reach -1.34 in the upcoming year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Let’s observe the current performance indicators for Roivant Sciences Ltd (ROIV). It’s Quick Ratio in the last reported quarter now stands at 33.70. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 695.83.
In the same vein, ROIV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.55, a figure that is expected to reach -0.31 in the next quarter, and analysts are predicting that it will be -1.34 at the market close of one year from today.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Going through the that latest performance of [Roivant Sciences Ltd, ROIV]. Its last 5-days volume of 6.85 million indicated improvement to the volume of 6.53 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 45.55% While, its Average True Range was 57.23.
Raw Stochastic average of Roivant Sciences Ltd (ROIV) in the period of the previous 100 days is set at 90.51%, which indicates a major rise in contrast to 50.85% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.79 that was higher than 0.45 volatility it exhibited in the past 100-days period.
